Historically, the documented cases of activating Src mutations are rare, with only one major study in colon cancer documenting 12% of cases with a truncating mutation at codon 531 110, which when functionally validated, was shown to lead to increased Src specificity and transformation of NIH 3T3 cells. This evidence concerns the gene SRC and malignant colon neoplasm.